View Document Preview and Link Open Document File Size: 49,22 KB Share Result on Facebook
Company IMS Health / D. Drug Use Data / Kilograms KG / Ceftaroline fosamil KG / Kilograms Antibacterial Drug Class Nitroimidazoles Metronidazole Tinidazole KG / Antibacterials KG / Epidemiology II Office / / Country United States / / IndustryTerm retail market / selected systemic antibacterial drug products / retail* / non-retail channels / e.g. retail pharmacies / retail / retail and non-retail channels / non-retail markets / selected diagnostic products / home healthcare providers / food stores / outpatient retail pharmacies / combination products / non-retail** channels / non-retail settings / drug products / outpatient retail pharmacy settings / / OperatingSystem OSE / / Organization office of Surveillance / FDA / / Person Hina Mehta / Tracy Pham / / Position Analyst Division / Deputy Director for Drug Use Division / Director / EXECUTIVE / Director Office / Leader Division / / Product Kanamycin / Ceftazidime / Levofloxacin / Colistimethate / Cefdinir / Piperacillin / Cephalexin / Sulfisoxazole / Cefazolin / Ofloxacin / trimethoprim / Azithromycin / Penicillin / Metronidazole / Norfloxacin / Linezolid / amoxicillin / Sulfadiazine / Cephradine / Cefprozil / Gentamicin / Cefadroxil / Cefuroxime axetil / Doxycycline / Cefotaxime / ampicillin / Cefoxitin / Clarithromycin / Erythromycin / Ciprofloxacin / Cephalothin / Chloramphenicol / Rifampin / Nitrofurantoin / sulfamethoxazole / Cefuroxime / Cefotetan / Cefaclor / Ceftriaxone / Tobramycin / / SocialTag 
Department of Health and Human Services Public Health Service Food and Drug Administration Center for Drug Evaluation and Research Office of Surveillance and Epidemiology Drug Use Review